Usefulness of automatic assessment for longitudinal strain to diagnose wild-type transthyretin amyloid cardiomyopathy

被引:1
|
作者
Usuku, Hiroki [1 ,2 ,3 ]
Yamamoto, Eiichiro [2 ,3 ]
Sueta, Daisuke [2 ,3 ]
Imamura, Kanako [1 ]
Oike, Fumi [2 ,3 ]
Marume, Kyohei [2 ,3 ]
Ishii, Masanobu [2 ,3 ]
Hanatani, Shinsuke [2 ,3 ]
Arima, Yuichiro [2 ,3 ]
Takashio, Seiji [2 ,3 ]
Oda, Seitaro [4 ]
Kawano, Hiroaki [2 ,3 ]
Ueda, Mitsuharu [3 ,5 ]
Matsui, Hirotaka [6 ]
机构
[1] Kumamoto Univ Hosp, Dept Lab Med, Kumamoto, Japan
[2] Kumamoto Univ, Grad Sch Med Sci, Dept Cardiovasc Med, 1-1-1 Honjo,Chuo Ku, Kumamoto 8608556, Japan
[3] Kumamoto Univ, Fac Life Sci, Ctr Metab Regulat Hlth Aging, Kumamoto, Japan
[4] Kumamoto Univ, Fac Life Sci, Dept Diagnost Radiol, Kumamoto, Japan
[5] Kumamoto Univ, Grad Sch Med Sci, Dept Neurol, Kumamoto, Japan
[6] Kumamoto Univ, Fac Life Sci, Dept Mol Lab Med, Kumamoto, Japan
来源
IJC HEART & VASCULATURE | 2023年 / 47卷
基金
日本学术振兴会;
关键词
Transthyretin amyloid cardiomyopathy; Two-dimensional speckle tracking~echocardiography; Relative apical longitudinal strain index; Automatic assessment; AMERICAN SOCIETY; SYSTEMIC AMYLOIDOSIS; EUROPEAN ASSOCIATION; CARDIAC AMYLOIDOSIS; ECHOCARDIOGRAPHY; RECOMMENDATIONS; TRACKING; UPDATE;
D O I
10.1016/j.ijcha.2023.101227
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Left ventricular (LV) apical sparing by transthoracic echocardiography (TTE) has not been widely accepted to diagnose transthyretin amyloid cardiomyopathy (ATTR-CM), because it is time consuming and requires a level of expertise. We hypothesized that automatic assessment may be the solution for these problems. Methods-and-Results: We enrolled 63 patients aged >= 70 years who underwent Tc-99m-labeled pyrophosphate (Tc-99m-PYP) scintigraphy on suspicion of ATTR-CM and performed TTE by EPIQ7G, and had enough information for two-dimensional speckle tracking echocardiography at Kumamoto University Hospital from January 2016 to December 2019. LV apical sparing was described as a high relative apical longitudinal strain (LS) index (RapLSI). Measurement of LS was repeated using the same apical images with three different measurement packages as follows: (1) full-automatic assessment, (2) semi-automatic assessment, and (3) manual assessment. The calculation time for full-automatic assessment (14.7 +/- 1.4 sec/patient) and semi-automatic assessment (66.7 +/- 14.4 sec/patient) were significantly shorter than that for manual assessment (171.2 +/- 59.7 sec/patient) (p < 0.01 for both). Receiver operating characteristic curve analysis showed that the area under curve of the RapLSI evaluated by full-automatic assessment for predicting ATTR-CM was 0.70 (best cut-off point; 1.14 [sensitivity 63%, specificity 81%]), by semi-automatic assessment was 0.85 (best cut-off point; 1.00 [sensitivity, 66%; specificity, 100%]) and by manual assessment was 0.83 (best cut-off point; 0.97 [sensitivity, 72%; specificity, 97%]). Conclusion: There was no significant difference between the diagnostic accuracy of RapLSI estimated by semiautomatic assessment and that estimated by manual assessment. Semi-automatically assessed RapLSI is useful to diagnose ATTR-CM in terms of rapidity and diagnostic accuracy.
引用
收藏
页数:8
相关论文
共 50 条
  • [21] Correlation Between Cardiac Images, Biomarkers, and Amyloid Load in Wild-Type Transthyretin Amyloid Cardiomyopathy
    Morioka, Mami
    Takashio, Seiji
    Nakashima, Naoya
    Nishi, Masato
    Fujiyama, Akira
    Hirakawa, Kyoko
    Hanatani, Shinsuke
    Usuku, Hiroki
    Yamamoto, Eiichiro
    Kidoh, Masafumi
    Oda, Seitaro
    Matsushita, Kenichi
    Ueda, Mitsuharu
    Tsujita, Kenichi
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2022, 11 (12):
  • [22] Prognostic utility of echocardiographic assessment in wild type transthyretin amyloid cardiomyopathy
    Tamara Neves Pereira, M. Maria
    Tinoco, M.
    Pinheiro, M. Castro L.
    Azevedo, O.
    Ferreira, F.
    Lourenco, A.
    EUROPEAN JOURNAL OF HEART FAILURE, 2023, 25 : 371 - 371
  • [23] Interatrial septal 99mTc-pyrophosphate uptake and reduced strain in wild-type transthyretin amyloid cardiomyopathy
    Tadao Aikawa
    Hisataka Maki
    Tatsuro Ibe
    Osamu Manabe
    Noriko Oyama-Manabe
    Journal of Nuclear Cardiology, 2022, 29 : 363 - 366
  • [24] Interatrial septal 99mTc-pyrophosphate uptake and reduced strain in wild-type transthyretin amyloid cardiomyopathy
    Aikawa, Tadao
    Maki, Hisataka
    Ibe, Tatsuro
    Manabe, Osamu
    Oyama-Manabe, Noriko
    JOURNAL OF NUCLEAR CARDIOLOGY, 2022, 29 (01) : 363 - 366
  • [25] AMYLOID POLYNEUROPATHY CAUSED BY WILD-TYPE TRANSTHYRETIN
    Lam, Lynda
    Margeta, Marta
    Layzer, Robert
    MUSCLE & NERVE, 2015, 52 (01) : 146 - 149
  • [26] Clinical characteristics, outcome, and therapeutic effect of tafamidis in wild-type transthyretin amyloid cardiomyopathy
    Takashio, Seiji
    Morioka, Mami
    Ishii, Masanobu
    Morikawa, Kei
    Hirakawa, Kyoko
    Hanatani, Shinsuke
    Oike, Fumi
    Usuku, Hiroki
    Kidoh, Masafumi
    Oda, Seitaro
    Yamamoto, Eiichiro
    Matsushita, Kenichi
    Ueda, Mitsuharu
    Tsujita, Kenichi
    ESC HEART FAILURE, 2023, 10 (04): : 2319 - 2329
  • [27] A machine learning model for identifying patients at risk for wild-type transthyretin amyloid cardiomyopathy
    Huda, Ahsan
    Castano, Adam
    Niyogi, Anindita
    Schumacher, Jennifer
    Stewart, Michelle
    Bruno, Marianna
    Hu, Mo
    Ahmad, Faraz S.
    Deo, Rahul C.
    Shah, Sanjiv J.
    NATURE COMMUNICATIONS, 2021, 12 (01)
  • [28] Suspicion, screening, and diagnosis of wild-type transthyretin amyloid cardiomyopathy: a systematic literature review
    Bay, Katrine
    Gustafsson, Finn
    Maiborg, Michael
    Bagger-Bahnsen, Anne
    Strand, Anne Mette
    Pilgaard, Trine
    Poulsen, Steen Hvitfeldt
    ESC HEART FAILURE, 2022, 9 (03): : 1524 - 1541
  • [29] LIFETIME HOSPITAL COSTS OF PATIENTS SUFFERING FROM WILD-TYPE TRANSTHYRETIN AMYLOID CARDIOMYOPATHY
    Pilgaard, T.
    Pedersen, M.
    Strand, A.
    Molgaard, H.
    Poulsen, S.
    VALUE IN HEALTH, 2020, 23 : S331 - S331
  • [30] A simple staging system using biomarkers for wild-type transthyretin amyloid cardiomyopathy in Japan
    Nakashima, Naoya
    Takashio, Seiji
    Morioka, Mami
    Nishi, Masato
    Yamada, Toshihiro
    Hirakawa, Kyoko
    Ishii, Masanobu
    Tabata, Noriaki
    Yamanaga, Kenshi
    Fujisue, Koichiro
    Sueta, Daisuke
    Kanazawa, Hisanori
    Hoshiyama, Tadashi
    Hanatani, Shinsuke
    Araki, Satoshi
    Usuku, Hiroki
    Yamamoto, Eiichiro
    Ueda, Mitsuharu
    Matsushita, Kenichi
    Tsujita, Kenichi
    ESC HEART FAILURE, 2022, 9 (03): : 1731 - 1739